PMD (PMD Solutions) develops RespiraSense, a wireless chest-worn sensor that continuously monitors respiratory rate and distinguishes physical movements to reduce false alarms. The device is positioned as an early-warning tool for patient deterioration and has use cases including patients with chronic obstructive pulmonary disease. PMD has secured customers in NHS hospitals and previously received funding from the EU Horizon 2020 programme. The company currently employs a small team of five in Cork and plans to expand staff this year with a focus on engineering and sales and marketing personnel. With the new capital it is targeting expansion into the Middle East (Saudi Arabia and the UAE) pending regulatory approval, and is eyeing Canada for its first North American market entry. PMD emphasizes improving accuracy in respiratory monitoring to avoid unnecessary clinical actions caused by false alarms.

Total raised

$2M

Funding rounds

1

Latest round

Equity

Latest activity

Jan 2020